Mental health problems lead to greater productivity loss than other chronic conditions

Depression and other mental health issues reduce the number of productivity-adjusted life years (PALYs) more than musculoskeletal diseases or cardiovascular diseases, according to a recent joint study by the University of Eastern Finland, the Finnish Social Insurance Institution (Kela), and Monash University in Australia.

UVXY ETF & The VIX Spike higher – here is why and what to expect next

July 7, 2023

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib

December 9, 2023

Last resort: Oncopeptides formally challenges FDA’s withdrawal of cancer drug’s accelerated approval

The FDA’s new, expedited process around accelerated approval withdrawals will be put to its first test with Oncopeptides’ 2021 accelerated approval of Pepaxto (melphalan flufenamide),

August 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.